GoodRx Holdings, Inc. (GDRX) stock
GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 11/3037% below fair value
$3.36−0.11 (-3.17%)
Close on Nov 18, 2026Market cap $1.15BP/E 84.0Yield –
GoodRx revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
GoodRx's revenue for the twelve months ending Jun 30, 2026 was $785.23M, down 1.8% year over year. For fiscal 2025 it was $796.85M, up 0.6% from the year before. The highest annual figure on record is $796.85M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $796.85M | +0.6% |
| FY2024 | Dec 31, 2024 | $792.32M | +5.6% |
| FY2023 | Dec 31, 2023 | $750.27M | -2.1% |
| FY2022 | Dec 31, 2022 | $766.55M | +2.8% |
| FY2021 | Dec 31, 2021 | $745.42M | +35.4% |
| FY2020 | Dec 31, 2020 | $550.70M | +41.9% |
| FY2019 | Dec 31, 2019 | $388.22M | +55.6% |
| FY2018 | Dec 31, 2018 | $249.52M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $200.41M | -1.3% |
| Q1 FY2026 | Mar 31, 2026 | $194.01M | -4.4% |
| Q4 FY2025 | Dec 31, 2025 | $194.79M | -1.9% |
| Q3 FY2025 | Sep 30, 2025 | $196.03M | +0.4% |
| Q2 FY2025 | Jun 30, 2025 | $203.07M | +1.2% |
| Q1 FY2025 | Mar 31, 2025 | $202.97M | +2.6% |
| Q4 FY2024 | Dec 31, 2024 | $198.58M | +1.0% |
| Q3 FY2024 | Sep 30, 2024 | $195.25M | +8.5% |
| Q2 FY2024 | Jun 30, 2024 | $200.61M | +5.8% |
| Q1 FY2024 | Mar 31, 2024 | $197.88M | +7.6% |
| Q4 FY2023 | Dec 31, 2023 | $196.64M | +6.8% |
| Q3 FY2023 | Sep 30, 2023 | $179.96M | -3.9% |
| Q2 FY2023 | Jun 30, 2023 | $189.68M | -1.1% |
| Q1 FY2023 | Mar 31, 2023 | $183.99M | -9.5% |
| Q4 FY2022 | Dec 31, 2022 | $184.11M | -13.7% |
| Q3 FY2022 | Sep 30, 2022 | $187.32M | -4.0% |
| Q2 FY2022 | Jun 30, 2022 | $191.80M | +8.6% |
| Q1 FY2022 | Mar 31, 2022 | $203.33M | +26.7% |
| Q4 FY2021 | Dec 31, 2021 | $213.26M | +38.9% |
| Q3 FY2021 | Sep 30, 2021 | $195.10M | +38.9% |
| Q2 FY2021 | Jun 30, 2021 | $176.64M | +43.3% |
| Q1 FY2021 | Mar 31, 2021 | $160.43M | +20.3% |
| Q4 FY2020 | Dec 31, 2020 | $153.54M | +35.6% |
| Q3 FY2020 | Sep 30, 2020 | $140.45M | +38.0% |
| Q2 FY2020 | Jun 30, 2020 | $123.30M | – |
| Q1 FY2020 | Mar 31, 2020 | $133.41M | – |
| Q4 FY2019 | Dec 31, 2019 | $113.26M | – |
| Q3 FY2019 | Sep 30, 2019 | $101.75M | – |
See a number that looks wrong?